SCHEMBL2432363

SCHEMBL2432363

OC1=CC=CN(c2cc(F)cc(Oc3cccnc3)c2)C1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 6/20 0.51
GRM5 P41594 2/20 0.44
LMNA P02545 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
HTT P42858 1/20 0.36
FFAR1 O14842 1/20 0.36
NPC1 O15118 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
PPARD Q03181 1/20 0.34
CYP19A1 P11511 2/20 0.34
MET P08581 1/20 0.34
MAP2K1 Q02750 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30471933 0.76 CYP11B2 (0.40) HTT
SCHEMBL2432361 0.75 FFAR4 (0.51) FFAR4GRM5LMNATDP1HTT
SCHEMBL6901598 0.68 FFAR4 (0.57) FFAR4GRM5LMNATDP1HTT
SCHEMBL1721039 0.68 FFAR4 (0.62) FFAR4GRM5LMNATDP1HTT
SCHEMBL1720348 0.68 FFAR4 (0.56) FFAR4GRM5LMNATDP1HTT
SCHEMBL1720331 0.68 ALDH1A1 (0.59) FFAR4GRM5LMNATDP1HTT
SCHEMBL4457253 0.68 LMNA (0.56) FFAR4GRM5LMNATDP1HTT
SCHEMBL1724866 0.68 FFAR4 (1.00) FFAR4GRM5LMNATDP1HTT
SCHEMBL1721366 0.67 FFAR4 (0.68) FFAR4GRM5LMNATDP1FFAR1
SCHEMBL1724515 0.67 FFAR4 (1.00) FFAR4GRM5FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2542076-A1 INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS Merck Sharp & Dohme Corp. (US) 2013-01-09 EP disclosed
WO-2011109254-A1 INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS MERCK SHARP & DOHME CORP. (US) 2011-09-09 WO disclosed